Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Study to Assess the Efficacy and Safety of Traditional Chinese Medicine Combined With Entecavir for Patients With Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV

NCT02241616 is registered in ClinicalTrials.gov with ShuGuang Hospital as lead sponsor.

NCT NCT02241616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02241616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Study to Assess the Efficacy and Safety of Traditional Chinese Medicine Combined With Entecavir for Patients With Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV
Lead sponsor
ShuGuang Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2014
Completion date
June 30, 2019
Enrollment
350 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b virus related cirrhosis